Quality and safety of healthcare, our priority
Improving clinical and physical pathways
Institut Curie’s teams are mobilised to coordinate among themselves as well as with Institut Curie’s external partners to offer structured global healthcare and innovative treatments. Each patient is given a personalised care programme setting out their individual treatment plan.
Collaborating with patients and their families
Surveys are carried out to enable Institut Curie to undertake improvement actions adapted to patients’ expectations. The results of these surveys are available on request.
► Find out more : sophie.oger-hodge@curie.fr
A patients’ committee, composed of volunteers with personal experience of cancer treatment, assists the Hospital Group in its approach to quality improvement and care safety. The committee is kept informed of Institut Curie’s projects, but may also suggest its own ideas and projects. It reviews all patient information documents before they are distributed.
► Find out more : janine.dumont@curie.net
The commission in charge of relations with users and quality of care (CRUQPC) ensures respect for patients’ rights and contributes to improvement of the policy on care for the ill and their families.
Numerous partnership agreements have been concluded with associations focussing on patients’ needs, workshops, and events with patients in order to improve the quality of care within our establishments.
Establishing an evaluation of professional practices on a daily basis
The doctors and healthcare teams of Institut Curie are keen to engage in professional improvement projects.
These involve organising their activities to take on reduced waiting times, traceability of information, compliance with procedures and more.
Leading certification and accreditation procedures
The four-yearly Higher Health Authority (HAS) certification procedure for the Hospital Group is an essential phase.
The conclusions of these four-yearly assessments by the Haute Autorité de santé may be obtained simply upon request from the Quality Division, and are also accessible via the HAS site. ► Find out more
Other highly structured quality procedures are undertaken in several sectors: the medicines circuit, post-operative care, radiotherapy, laboratories and more. Find out more : sophie.oger-hodge@curie.fr
Measuring healthcare quality and safety
Institut Curie measures indicators annually to evaluate the effectiveness of the actions undertaken as well as to compare itself with other healthcare establishments at regional and national level. These indicators common to all healthcare establishments at national level are accessible to the public. ► See the latest results of Institut Curie’s indicators
You will also find them displayed in each of our establishments.
Developing a safety culture
Biovigilance. The objective: to prevent risks linked to the use of organs or tissues from the human body for therapeutic purposes, such as the risk of transmission of an infectious agent.
Identity monitoring. Identity monitoring is a risk management mechanism for patient identification, aimed at guaranteeing that all patients are correctly identified throughout their stay in the hospital and in exchanges of medical data between the hospital and doctors’ surgeries or other establishments.
Infection monitoring. The objective: to monitor infections arising in the hospital. Measures have been set up to reduce this risk.
Strict hygiene rules help to reduce the risks of healthcare-related infections. We recommend that both you and your visitors wash your hands after everyday activities and when entering or leaving your room, and maintain good bodily hygiene. In the collective interest, a patient may be placed in isolation without this being linked to the seriousness of their condition.
Haemovigilance and transfusion safety. This covers all the surveillance procedures carried out, from the collection of blood and its components up to the site of the recipients, in order to gather and evaluate information on unexpected or adverse effects resulting from the therapeutic use of labile blood products and to prevent their onset.
Materials monitoring.This involves all the resources deployed to ensure the safety of patients and staff when using medical devices.
Pharmacovigilance. Its purpose is to monitor the risk of adverse effects arising from the use of medicines.
Radiation protection. The mechanisms deployed ensure the safety of both patients and staff. Institut Curie is recognised as an international benchmark centre by the World Health Organisation (WHO).
Safety of fluids. Medical fluids or gas fluids are products that should be handled with caution. In spite of all the measures taken, a serious adverse event may always be possible. So that they can establish a relationship of trust, the healthcare professionals of the establishment undertake to keep the patient informed.
► Find out more: sophie.oger-hodge@curie.net
Respecting regulations and the environment
Institut Curie provides periodic regulatory monitoring. The many regulatory obligations which concern healthcare establishments are planned and monitored over time. Since 2010, Institut Curie has been involved in a sustainable development procedure.
